Trivial dose levels
Eichholz, G.G.
Health Physics 45(1): 180-181
1983
ISSN/ISBN: 0017-9078 PMID: 6874348 Document Number: 213534
Document emailed within 1 workday
Related Documents
Khedun, S.M.; Maharaj, B.; Naicker, T. 1996: The effect of a low dose versus a conventional dose of hydrochlorothiazide on ventricular fibrillation threshold and electrolyte levels in laboratory rats Brazilian Journal of Medical and Biological Research 29(10): 1373-1378Watson, W.H. 1977: Trivial illness Practitioner 218(1307): 702-704
Soukop, M. 1990: A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S15-S19
Duggan, J.M. 1989: Technological triumph--trivial pursuit Australian and New Zealand Journal of Medicine 19(5): 506-508
Martínez-Menéndez, B.; Pinel-González, A. 2006: Migraine in childhood: a trivial condition? Revista de Neurologia 42(11): 643-646
Sansone, G.; Torraca, S.; Delfino, F.; Schettini, R. 2010: A case of apparently trivial flank pain Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(1): 82-84
Spivak, J.L. 1994: Sports hematology: serious concept or trivial pursuit. Introduction Seminars in Hematology 31(2): 99-101
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299
Hayase, R.; Yamamoto, J.; Yamamoto, M.; Kodama, J.; Tamada, T.; Kudoh, T. 1995: Pt levels following the infusion of daily low-dose cisplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 565-568
Rifkin, A.; Karajgi, B.; Doddi, S.; Cooper, T. 1990: Dose and blood levels of haloperidol in treatment of mania Psychopharmacology Bulletin 26(1): 144-146
Kelleher, J.; Davies, T.; Smith, C.L.; Walker, B.E.; Losowsky, M.S. 1972: The absorption of -tocopherol in the rat. I. the effect of different carriers and different dose levels International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 42(3): 394-402
Petersen, K.-U. 2011: Acetaminophen and the liver: damage at therapeutic dose levels? MMW Fortschritte der Medizin 153(Suppl 4): 137-142
Keown, P.A. 1988: Optimizing cyclosporine therapy: dose, levels, and monitoring Transplantation Proceedings 20(2 Suppl 2: 382-389
Otero, M.J.; Barrueco, M.; Mariño, E.L.; Gómez, F.; Domínquez-Gil, A. 1984: Serum levels, dose and response in prolonged treatment with theophylline Medicina Clinica 83(11): 447-449
Creaven, P.J.; Allen, L.M.; Muggia, F.M. 1972: Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity Cancer ChemoTherapy Reports 56(5): 573-578
Hennis, B.C.; Boomsma, D.I.; Fijnvandraat, K.; Gevers Leuven, J.A.; Peters, M.; Kluft, C. 1995: Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way Thrombosis and Haemostasis 73(3): 484-487
Pullar, T.; Hunter, J.A.; Capell, H.A. 1985: Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy British Journal of Rheumatology 24(3): 269-276
Kalous, O.; Mayer, J.; Malásková, L. 2001: High-dose busulfan--monitoring plasma levels and dosage adjustments in adults Casopis Lekaru Ceskych 140(23): 724-728
Momcilović, B. 1974: Comparative metabolism of high lead dose levels in suckling and adult rats Arhiv Za Higijenu Rada i Toksikologiju 25(3): 359-369
da Silva, L.C.; Sette Júnior, H.; Christo, C.; Sette, P.C.; Kaye, B. 1980: Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose Revista do Instituto de Medicina Tropical de Sao Paulo 22(1 Suppl 4): 58-64 175-81